{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,6]],"date-time":"2026-06-06T07:36:43Z","timestamp":1780731403851,"version":"3.54.1"},"reference-count":24,"publisher":"Elsevier BV","issue":"50","license":[{"start":{"date-parts":[[2014,11,1]],"date-time":"2014-11-01T00:00:00Z","timestamp":1414800000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,11,1]],"date-time":"2014-11-01T00:00:00Z","timestamp":1414800000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2014,2,28]],"date-time":"2014-02-28T00:00:00Z","timestamp":1393545600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/3.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2014,11]]},"DOI":"10.1016\/j.vaccine.2014.01.096","type":"journal-article","created":{"date-parts":[[2014,2,13]],"date-time":"2014-02-13T07:15:38Z","timestamp":1392275738000},"page":"6847-6854","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":24,"title":["Enhanced early innate and T cell-mediated responses in subjects immunized with Anthrax Vaccine Adsorbed Plus CPG 7909 (AV7909)"],"prefix":"10.1016","volume":"32","author":[{"given":"Jacob T.","family":"Minang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jon R.","family":"Inglefield","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea M.","family":"Harris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janet L.","family":"Lathey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8212-4802","authenticated-orcid":false,"given":"David G.","family":"Alleva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diane L.","family":"Sweeney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert J.","family":"Hopkins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael J.","family":"Lacy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edward W.","family":"Bernton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"August (37)","key":"10.1016\/j.vaccine.2014.01.096_bib0005","doi-asserted-by":"crossref","first-page":"6313","DOI":"10.1016\/j.vaccine.2011.05.047","article-title":"Marked enhancement of the immune response to BioThrax\u00ae (Anthrax Vaccine Adsorbed) by the TLR9 agonist CPG 7909 in healthy volunteers","volume":"29","author":"Rynkiewicz","year":"2011","journal-title":"Vaccine"},{"issue":"February (2)","key":"10.1016\/j.vaccine.2014.01.096_bib0010","first-page":"221","article-title":"Activation of innate immunity in healthy Macaca mulatta macaques by a single subcutaneous dose of GMP CpG 7909: safety data and interferon-inducible protein-10 kinetics for humans and macaques","volume":"15","author":"Cooper","year":"2008","journal-title":"Clin Vaccine Immunol"},{"issue":"November (6)","key":"10.1016\/j.vaccine.2014.01.096_bib0015","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1097\/00002371-200411000-00006","article-title":"Induction of systemic TH1-like innate immunity in normal volunteers following subcutaneous but not intravenous administration of CPG 7909, a synthetic B-class CpG oligodeoxynucleotide TLR9 agonist","volume":"27","author":"Krieg","year":"2004","journal-title":"J Immunother"},{"issue":"August (23\u201324)","key":"10.1016\/j.vaccine.2014.01.096_bib0020","doi-asserted-by":"crossref","first-page":"3136","DOI":"10.1016\/j.vaccine.2004.01.058","article-title":"Safety and immunogenicity of CPG 7909 injection as an adjuvant to Fluarix influenza vaccine","volume":"22","author":"Cooper CL","year":"2004","journal-title":"Vaccine"},{"issue":"February (1)","key":"10.1016\/j.vaccine.2014.01.096_bib0025","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.coi.2009.03.011","article-title":"Antigen presentation by dendritic cells in vivo","volume":"21","author":"Segura","year":"2009","journal-title":"Curr Opin Immunol"},{"issue":"February (2)","key":"10.1016\/j.vaccine.2014.01.096_bib0030","doi-asserted-by":"crossref","first-page":"211","DOI":"10.3109\/10428194.2011.608451","article-title":"Phase I clinical trial of CpG oligonucleotide 7909 (PF-03512676) in patients with previously treated chronic lymphocytic leukemia","volume":"53","author":"Zent","year":"2012","journal-title":"Leuk Lymphoma"},{"issue":"April (8)","key":"10.1016\/j.vaccine.2014.01.096_bib0035","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1093\/infdis\/jis107","article-title":"Clinical evaluation of safety and immunogenicity of PADRE-cytomegalovirus (CMV) and tetanus-CMV fusion peptide vaccines with or without PF03512676 adjuvant","volume":"205","author":"La Rosa","year":"2012","journal-title":"J Infect Dis"},{"issue":"October (7)","key":"10.1016\/j.vaccine.2014.01.096_bib0040","doi-asserted-by":"crossref","first-page":"4433","DOI":"10.4049\/jimmunol.173.7.4433","article-title":"Human plasmacytoid dendritic cells activated by CpG oligodeoxynucleotides induce the generation of CD4+ CD25+ regulatory T cells","volume":"173","author":"Moseman","year":"2004","journal-title":"J Immunol"},{"issue":"May (9)","key":"10.1016\/j.vaccine.2014.01.096_bib0045","doi-asserted-by":"crossref","first-page":"4465","DOI":"10.4049\/jimmunol.170.9.4465","article-title":"Activation with CpG-A and CpG-B oligonucleotides reveals two distinct regulatory pathways of type I IFN synthesis in human plasmacytoid dendritic cells","volume":"170","author":"Kerkmann","year":"2003","journal-title":"J Immunol"},{"issue":"January (1)","key":"10.1016\/j.vaccine.2014.01.096_bib0050","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1002\/eji.200324032","article-title":"Characterization of three CpG oligodeoxynucleotide classes with distinct immunostimulatory activities","volume":"34","author":"Vollmer","year":"2004","journal-title":"Eur J Immunol"},{"issue":"March (6)","key":"10.1016\/j.vaccine.2014.01.096_bib0055","doi-asserted-by":"crossref","first-page":"2162","DOI":"10.1182\/blood-2003-04-1091","article-title":"CpG-A and CpG-B oligonucleotides differentially enhance human peptide-specific primary and memory CD8+ T-cell responses in vitro","volume":"103","author":"Rothenfusser","year":"2004","journal-title":"Blood"},{"issue":"November (3)","key":"10.1016\/j.vaccine.2014.01.096_bib0060","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1046\/j.1365-2567.2002.01501.x","article-title":"Interleukin-6 promotes the production of interleukin-4 and interleukin-5 by interleukin-2-dependent and -independent mechanisms in freshly isolated human T cells","volume":"107","author":"Heijink","year":"2002","journal-title":"Immunology"},{"issue":"October (10)","key":"10.1016\/j.vaccine.2014.01.096_bib0065","doi-asserted-by":"crossref","first-page":"4538","DOI":"10.1128\/IAI.00324-08","article-title":"The anthrax vaccine adsorbed vaccine generates protective antigen (PA)-specific CD4+ T cells with a phenotype distinct from that of naive PA T cells","volume":"76","author":"Kwok","year":"2008","journal-title":"Infect Immun"},{"issue":"June (30)","key":"10.1016\/j.vaccine.2014.01.096_bib0070","doi-asserted-by":"crossref","first-page":"3051","DOI":"10.1016\/j.vaccine.2013.04.063","article-title":"Randomized, double-blind, placebo-controlled, safety and immunogenicity study of 4 formulations of Anthrax Vaccine Adsorbed Plus CPG 7909 (AV7909) in healthy adult volunteers","volume":"31","author":"Hopkins","year":"2013","journal-title":"Vaccine"},{"issue":"November (3\u20134)","key":"10.1016\/j.vaccine.2014.01.096_bib0075","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1007\/s002510050595","article-title":"SYFPEITHI: database for MHC ligands and peptide motifs","volume":"50","author":"Rammensee","year":"1999","journal-title":"Immunogenetics"},{"issue":"December (12)","key":"10.1016\/j.vaccine.2014.01.096_bib0080","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1093\/bioinformatics\/17.12.1236","article-title":"ProPred: prediction of HLA-DR binding sites","volume":"17","author":"Singh","year":"2001","journal-title":"Bioinformatics"},{"issue":"October (10)","key":"10.1016\/j.vaccine.2014.01.096_bib0085","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1007\/s00262-010-0875-4","article-title":"Response definition criteria for ELISPOT assays revisited","volume":"59","author":"Moodie","year":"2010","journal-title":"Cancer Immunol Immunother"},{"issue":"August (2)","key":"10.1016\/j.vaccine.2014.01.096_bib0090","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1079\/BJN20051467","article-title":"Parenteral nutrition providing a restricted amount of linoleic acid in severely burned patients: a randomised double-blind study of an olive oil-based lipid emulsion v. medium\/long-chain triacylglycerols","volume":"94","author":"Garc\u00eda-de-Lorenzo","year":"2005","journal-title":"Br J Nutr"},{"issue":"November (6)","key":"10.1016\/j.vaccine.2014.01.096_bib0095","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1097\/00002371-200411000-00006","article-title":"Induction of systemic TH1-like innate immunity in normal volunteers following subcutaneous but not intravenous administration of CPG 7909, a synthetic B-class CpG oligodeoxynucleotide TLR9 agonist","volume":"27","author":"Krieg","year":"2004","journal-title":"J Immunother"},{"issue":"November (11)","key":"10.1016\/j.vaccine.2014.01.096_bib0100","doi-asserted-by":"crossref","first-page":"7495","DOI":"10.1128\/IAI.73.11.7495-7501.2005","article-title":"Murine macrophages kill the vegetative form of Bacillus anthracis","volume":"73","author":"Kang","year":"2005","journal-title":"Infect Immun"},{"issue":"January (1)","key":"10.1016\/j.vaccine.2014.01.096_bib0105","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1128\/IAI.05439-11","article-title":"Antibacterial role for natural killer cells in host defense to Bacillus anthracis","volume":"80","author":"Gonzales","year":"2012","journal-title":"Infect Immun"},{"issue":"11","key":"10.1016\/j.vaccine.2014.01.096_bib0110","doi-asserted-by":"crossref","first-page":"e1001199","DOI":"10.1371\/journal.ppat.1001199","article-title":"Interferon-inducible CXC chemokines directly contribute to host defense against inhalational anthrax in a murine model of infection","volume":"6","author":"Crawford","year":"2010","journal-title":"PLoS Pathog"},{"issue":"January (1)","key":"10.1016\/j.vaccine.2014.01.096_bib0115","doi-asserted-by":"crossref","first-page":"e1002481","DOI":"10.1371\/journal.ppat.1002481","article-title":"Mechanisms of NK cell-macrophage Bacillus anthracis crosstalk: A balance between stimulation by spores and differential disruption by toxins","volume":"8","author":"Klezovich-B\u00e9nard","year":"2012","journal-title":"PLoS Pathog"},{"issue":"March (3)","key":"10.1016\/j.vaccine.2014.01.096_bib0120","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1172\/JCI23373","article-title":"Rapid and strong human CD8+ T cell responses to vaccination with peptide, IFA, and CpG oligodeoxynucleotide 7909","volume":"115","author":"Speiser","year":"2005","journal-title":"J Clin Invest"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X14001595?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X14001595?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T10:20:48Z","timestamp":1759400448000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X14001595"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,11]]},"references-count":24,"journal-issue":{"issue":"50","published-print":{"date-parts":[[2014,11]]}},"alternative-id":["S0264410X14001595"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2014.01.096","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2014,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Enhanced early innate and T cell-mediated responses in subjects immunized with Anthrax Vaccine Adsorbed Plus CPG 7909 (AV7909)","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2014.01.096","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}